Increased Echogenicity and Radiodense Foci on Echocardiogram and MicroCT in Murine Myocarditis

Objectives To address the question as to whether echocardiographic and/or microcomputed tomography (microCT) analysis can be utilized to assess the extent of Coxsackie B virus (CVB) induced myocarditis in the absence of left ventricular dysfunction in the mouse. Background Viral myocarditis is a significant clinical problem with associated inflammation of the myocardium and myocardial injury. Murine models of myocarditis are commonly used to study the pathophysiology of the disease, but methods for imaging the mouse myocardium have been limited to echocardiographic assessment of ventricular dysfunction and, to a lesser extent, MRI imaging. Methods Using a murine model of myocarditis, we used both echocardiography and microCT to assess the extent of myocardial involvement in murine myocarditis using both wild-type mice and CVB cleavage-resistant dystrophin knock-in mice. Results Areas of increased echogenicity were only observed in the myocardium of Coxsackie B virus infected mice. These echocardiographic abnormalities correlated with the extent of von Kossa staining (a marker of membrane permeability), inflammation, and fibrosis. Given that calcium phosphate uptake as imaged by von Kossa staining might also be visualized using microCT, we utilized microCT imaging which allowed for high-resolution, 3-dimensional images of radiodensities that likely represent calcium phosphate uptake. As with echocardiography, only mice infected with Coxsackie B virus displayed abnormal accumulation of calcium within individual myocytes indicating increased membrane permeability only upon exposure to virus. Conclusions These studies demonstrate new, quantitative, and semi-quantitative imaging approaches for the assessment of myocardial involvement in the setting of viral myocarditis in the commonly utilized mouse model of viral myocarditis.

[1]  Stefan L. Zimmerman,et al.  Myocardial calcifications: pathophysiology, etiologies, differential diagnoses, and imaging findings. , 2015, Journal of cardiovascular computed tomography.

[2]  K. Klingel,et al.  Heme Oxygenase-1 Mediates Oxidative Stress and Apoptosis in Coxsackievirus B3-Induced Myocarditis , 2014, Cellular Physiology and Biochemistry.

[3]  N. Dalton,et al.  Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy. , 2013, The Journal of clinical investigation.

[4]  U. Eriksson,et al.  Selective In Vivo Visualization of Immune-Cell Infiltration in a Mouse Model of Autoimmune Myocarditis by Fluorine-19 Cardiac Magnetic Resonance , 2013, Circulation. Cardiovascular imaging.

[5]  G. Schuler,et al.  Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. , 2012, JACC. Cardiovascular imaging.

[6]  L. Otterspoor,et al.  Sepsis-related myocardial calcification. , 2011, Circulation. Heart failure.

[7]  J. Bergelson,et al.  Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. , 2009, Cell host & microbe.

[8]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[9]  L. Cooper,et al.  Diagnosis and treatment of viral myocarditis. , 2009, Mayo Clinic proceedings.

[10]  A. McCulloch,et al.  Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. , 2008, The Journal of clinical investigation.

[11]  T. Hewett,et al.  Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. , 2007, The Journal of clinical investigation.

[12]  L. Cooper,et al.  Noninvasive imaging in myocarditis. , 2006, Journal of the American College of Cardiology.

[13]  S. Colan,et al.  Incidence, causes, and outcomes of dilated cardiomyopathy in children. , 2006, JAMA.

[14]  J. Towbin,et al.  Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. , 2003, Journal of the American College of Cardiology.

[15]  C. Badorff,et al.  Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: A genetic predisposition to viral heart disease , 2002, Nature Medicine.

[16]  S. Takata,et al.  Ultrasonic tissue characterization in acute myocarditis: a case report. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[17]  C. Badorff,et al.  Dissociation of Sarcoglycans and the Dystrophin Carboxyl Terminus From the Sarcolemma in Enteroviral Cardiomyopathy , 2000, Circulation research.

[18]  H. Kiyomoto,et al.  Echocardiographic observation of acute myocarditis with systemic lupus erythematosus. , 2000, Japanese circulation journal.

[19]  M. Martone,et al.  Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.

[20]  E. Itoh,et al.  An autopsied case of acute myocarditis with myocardial calcification. , 1997, Japanese circulation journal.

[21]  W. Mckenna,et al.  Coxsackie B viruses and human heart disease. , 1997, Current topics in microbiology and immunology.

[22]  R. Wessely,et al.  A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3 , 1996, Journal of virology.

[23]  R Hetzer,et al.  Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis. , 1996, European heart journal.

[24]  H. Olbrich,et al.  Calcium overload in human giant cell myocarditis. , 1990, Journal of clinical pathology.